12 results
8-K
EX-10.1
MIRM
Mirum Pharmaceuticals Inc
11 Sep 23
Departure of Directors or Certain Officers
4:16pm
, whether by you or the Company, must be brought in an individual capacity, and shall not be brought as a plaintiff (or claimant) or class member
8-K
EX-2.1
MIRM
Mirum Pharmaceuticals Inc
17 Jul 23
Mirum Pharmaceuticals Enters Agreement to Acquire Bile Acid Product Portfolio for the Treatment of Rare Liver Diseases from Travere Therapeutics
8:16am
written release by the claimant or plaintiff of the Indemnified Party from all liability in respect of such Third Party Claim.
(d) An Indemnified Party
8-K
EX-10.1
MIRM
Mirum Pharmaceuticals Inc
19 Nov 21
Entry into a Material Definitive Agreement
6:08am
compromise or settlement unless (i) such compromise or settlement includes as an unconditional term thereof, the giving by each claimant or plaintiff
8-K
EX-99.1
MIRM
Mirum Pharmaceuticals Inc
10 Dec 20
Revenue Interest Purchase Agreement
9:11am
, but, if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the Indemnified Party from
S-1/A
EX-10.18
bvrznlh
8 Jul 19
IPO registration (amended)
6:43am
S-1
EX-10.20
p0m351
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.17
29odpl
21 Jun 19
IPO registration
3:24pm
S-1
EX-10.18
qp52xm8oyb74hj
21 Jun 19
IPO registration
3:24pm
DRS
EX-10.20
zmgstqqwk8w dex2n
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.18
ven402s
18 Apr 19
Draft registration statement
12:00am
DRS
EX-10.17
v0300
18 Apr 19
Draft registration statement
12:00am
- Prev
- 1
- Next